��

Arbutus Biopharma

2 followers

‌

Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).

Industries

Headquarters

Warminster, United States

Employees

Links

Org chart

Michael McElhaugh

CEO

Michael McElhaugh

Collapse

David C. Hastings

Chief Financial Officer

Elizabeth Howard

EVP, General Counsel & Chief Compliance Officer

Michael J. Sofia Phd

Chief Scientific Officer

Chief Medical Officer

Catherine Coffey Ross

Vice President Commercial Development

Vice President Clinical Operations

Shannon Briscoe

Vice President Human Resources

Ganapati Reddy Pamulapati

Senior Vice President, Pharmaceutical Development And Manufacturing

Executive Director Of Information Technology & Information Security

Teams

Scientific and Research Team

13 members

Clinical Operations Team

8 members

Finance and Accounting

4 members

Leadership Team

3 members

Similar companies

Kura Oncology

19 followers

SpringWorks Therapeutics

6 followers

REVOLUTION Medicines

5 followers

Kymera Therapeutics

5 followers

Halozyme Therapeutics

4 followers

MindMed

4 followers

Summit Therapeutics

4 followers

Stemline Therapeutics

3 followers

CytomX

3 followers

Prelude Therapeutics

3 followers

Quantum-Si

2 followers

Explore companies